4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 94 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q1 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,050 | -29.6% | 1,575 | 0.0% | 0.00% | – |
| Q2 2023 | $28,460 | -7.3% | 1,575 | -11.8% | 0.00% | – |
| Q1 2023 | $30,701 | -19.2% | 1,786 | +5.1% | 0.00% | – |
| Q4 2022 | $38,000 | -17.4% | 1,699 | -70.3% | 0.00% | – |
| Q3 2022 | $46,000 | +15.0% | 5,719 | 0.0% | 0.00% | – |
| Q2 2022 | $40,000 | -53.5% | 5,719 | 0.0% | 0.00% | – |
| Q1 2022 | $86,000 | -33.3% | 5,719 | -2.8% | 0.00% | – |
| Q4 2021 | $129,000 | -18.4% | 5,886 | +0.2% | 0.00% | – |
| Q3 2021 | $158,000 | +12.1% | 5,875 | 0.0% | 0.00% | – |
| Q2 2021 | $141,000 | – | 5,875 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 377,777 | $15,659,000 | 5.43% |
| BVF INC/IL | 1,106,070 | $45,847,000 | 1.80% |
| Eagle Health Investments LP | 50,000 | $2,073,000 | 1.33% |
| Ally Bridge Group (NY) LLC | 150,000 | $6,218,000 | 1.07% |
| Casdin Capital, LLC | 780,555 | $32,354,000 | 0.96% |
| VIKING GLOBAL INVESTORS LP | 3,937,914 | $163,227,000 | 0.45% |
| Pinz Capital Management, LP | 19,900 | $825,000 | 0.38% |
| ArrowMark Colorado Holdings LLC | 1,063,744 | $44,092,000 | 0.34% |
| Perceptive Advisors | 600,256 | $24,881,000 | 0.27% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $829,000 | 0.23% |